Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L17 pseudogene 35 (RPL17P35) is a processed pseudogene in the human genome related to the gene for ribosomal protein L17. Pseudogenes like RPL17P35 are non-functional gene copies, usually arising from retrotransposition or duplication events. While the parental RPL17 gene encodes a component of the ribosome 60S subunit, RPL17P35 itself does not produce a functional protein and has no known direct biological function, therapeutic relevance, or disease association. Most ribosomal protein pseudogenes exist as evolutionary remnants, with occasional reports of regulatory activity for some pseudogenes, but RPL17P35 is not among the few with demonstrated activity or biological impact.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L17 pseudogene 35 (RPL17P35).